Cargando…

COT-13 Current situation and problems of cancer genomic profiling test in Kyoto University Hospital

Objective: Kyoto University Hospital has introduced the cancer genomic profiling tests, Oncoprime in 2015, Guardant360 in 2018, which are not under insurance coverage, FoundationOne CDx(F1CDx) and OncoGuide NCC Oncopanel system(NCC OP) in 2019, which received approval for insurance coverage for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arakawa, Yoshiki, Suga, Junko, Terada, Yukinori, Nakajima, Kohei, Tanji, Masahiro, Mineharu, Yohei, Muto, Manabu, Miyamoto, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699132/ http://dx.doi.org/10.1093/noajnl/vdaa143.099

Ejemplares similares

COT-07 Cerebrovascular complications in adult patients with malignant brain tumor
por: Mineharu, Yohei, et al.
Publicado: (2020)

COT-11 EFFECT OF PHYSICIAN SUPPORTS ON QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL BRAIN TUMOR RESEARCH
por: Furukawa, Keiko, et al.
Publicado: (2019)

COT-12 The role of clinical research professional in the registration study of pediatric solid tumor in Japan Children’s Cancer Group
por: Furukawa, Keiko, et al.
Publicado: (2020)

TB-3 miR-33a depletion accelerate medulloblastoma generation and invasion
por: Mineharu, Yohei, et al.
Publicado: (2021)

Malignant transformation of central neurocytoma with dissemination 17 years after initial treatment: illustrative case
por: Kojima, Kazuhiro, et al.
Publicado: (2022)

Papillary glioneuronal tumor growing slowly for 26 years: illustrative case
por: Shinno, Kazuma, et al.
Publicado: (2021)

THER-07. INHIBITION OF THE RAS SIGNALING ENHANCES VIRAL ONCOLYSIS IN MALIGNANT GLIOMAS
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy
por: Hattori, Etsuko Yamamoto, et al.
Publicado: (2023)

TB-01 HUMAN IPS CELL-DERIVED BRAIN TUMOR MODEL UNCOVERS THE EMBRYONIC STEM CELL SIGNATURE AS A KEY DRIVER IN ATYPICAL TERATOID/RHABDOID TUMOR
por: Terada, Yukinori, et al.
Publicado: (2019)

Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
por: Makino, Yasuhide, et al.
Publicado: (2021)

Mixed germ cell tumor infiltrating the pineal gland without elevated tumor markers: illustrative case
por: Shiomi, Koji, et al.
Publicado: (2021)

Central nervous system mature teratoma producing carbohydrate antigen 19-9: illustrative case
por: Takeuchi, Shu, et al.
Publicado: (2022)

PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes
por: Liu, Bin, et al.
Publicado: (2018)

LGG-38. GENETIC ANALYSIS OF NEUROEPITHELIAL TUMORS IN THE PEDIATRIC AND ADOLESCENT AND YOUNG ADULT AGE IN A SINGLE INSTITUTE
por: Makino, Yasuhide, et al.
Publicado: (2020)

ET-06 Suppression of glioblastoma through novel drug based on “Gene Switch Technology”
por: Yamamoto, Etsuko, et al.
Publicado: (2020)

Cerebral Tufted Angioma with Gradually Developing Peritumoral Edema: A Case Report
por: HASEGAWA, Takashi, et al.
Publicado: (2022)

COT-18 Prognosis and problems about secondary intracranial neoplasm in childhood cancer survivors: a single-institution retrospective cohort study
por: Kagawa, Naoki, et al.
Publicado: (2020)

Impact of Intraoperative 3-Tesla MRI on Endonasal Endoscopic Pituitary Adenoma Resection and a Proposed New Scoring System for Predicting the Utility of Intraoperative MRI
por: TANJI, Masahiro, et al.
Publicado: (2020)

COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020)

Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group
por: AOKI, Tomokazu, et al.
Publicado: (2017)

Preoperative obliteration of choroidal arteries in the treatment of large hypervascular tumors in the lateral ventricle
por: Yamao, Yukihiro, et al.
Publicado: (2021)

COT-01 Experience of introducing alternating electric field therapy for an elderly glioblastoma patient living alone
por: Hayashi, Nobuhide, et al.
Publicado: (2020)

COT-31 Risk Factors for the Development of Skin Rash with Levetiracetam and Lacosamide in Patients with Glioma
por: Onodera, Mikoto, et al.
Publicado: (2021)

PEDT-5 Problem for the guideline of CNS germ cell tumors
por: Nakamura, Hideo, et al.
Publicado: (2021)

COT-12 Clinical feature of end-stage glioblastomas
por: Saito, Norihiko, et al.
Publicado: (2021)

COT-17 Cancer genomic medicine at Kobe University Hospital
por: Tanaka, Kazuhiro, et al.
Publicado: (2020)

COT-7 Online supports for opening of the tumor treating field
por: Sadahiro, Hirokazu, et al.
Publicado: (2021)

MBRS-22. SIGNIFICANCE OF RNF213 IN TUMORGENICITY OF MEDULLOBLASTOMA
por: Mineharu, Yohei, et al.
Publicado: (2020)

COT-3 Exosomal microRNA expression signature in blood and cerebrospinal fluid of glioblastoma patients
por: Yamashita, Daisuke, et al.
Publicado: (2021)

COT-02 The opening of tumor treating fields with online support system
por: Sadahiro, Hirokazu, et al.
Publicado: (2020)

COT-9 Prognostic impact of hypercoagulation in glioblastoma and molecular mechanism thereof
por: Negoto, Tetsuya, et al.
Publicado: (2021)

The association of ectopic craniopharyngioma in the fourth ventricle with familial adenomatous polyposis: illustrative case
por: Uemura, Hiroya, et al.
Publicado: (2022)

COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2020)

GCT-50. LONG-TERM OUTCOMES OF INTRACRANIAL GERMINOMA IN A SINGLE INSTITUTION
por: Yamamoto, Etsuko, et al.
Publicado: (2020)

MPC-19 DIAGNOSTIC APPROACH IN HISTOPATHOLOGICALLY CHALLENGING CASES IN KYOTO UNIVERSITY HOSPITAL
por: Takeuchi, Yasuhide, et al.
Publicado: (2022)

Infrequent RAS mutation is not associated with specific histological phenotype in gliomas
por: Makino, Yasuhide, et al.
Publicado: (2021)

A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
por: Hattori, Etsuko Yamamoto, et al.
Publicado: (2022)

Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
por: Hattori, Etsuko Yamamoto, et al.
Publicado: (2022)

COT-11 Administration of Bevacizumab for patients who failed to complete Stupp regimen after glioblastoma surgery
por: Kon, Takashi, et al.
Publicado: (2020)

COT-13 Luminance analysis of 5-aminolevulinic acid using Image J for malignant brain tumor
por: Kon, Takashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t1i2vaskp4obcp3licp3vbdejh